Thrombosis and Haemostasis


Publication Venue For

  • Plasma Levels of Big Endothelin-1 Are Associated with Renal Insufficiency and In-Hospital Mortality of Immune Thrombotic Thrombocytopenic Purpura.  122:344-352. 2022
  • Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A.  121:1674-1676. 2021
  • Exome Sequencing Identifies Abnormalities in Glycosylation and ANKRD36C in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura.  121:506-517. 2021
  • Apolipoprotein B100/Low-Density Lipoprotein Regulates Proteolysis and Functions of von Willebrand Factor under Arterial Shear.  119:1933-1946. 2019
  • Platelet Glycoprotein VI Haplotypes and the Presentation of Paediatric Sepsis.  119:431-438. 2019
  • Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).  118:1305-1315. 2018
  • Low Plasma ADAMTS13 Activity Is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Paediatric Trauma.  118:676-687. 2018
  • D-dimer and the risk of stroke and coronary heart disease the REasons for geographic and racial differences in stroke (REGARDS) study.  117:618-624. 2017
  • Haemostasis biomarkers and risk of intracerebral haemorrhage in the reasons for geographic and racial differences in stroke study.  117:1808-1815. 2017
  • Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.  117:691-699. 2017
  • Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia.  117:580-588. 2017
  • The impact of statin therapy on plasma levels of von Willebrand factor antigen: Systematic review and meta-analysis of Randomised placebo-controlled trials.  115:520-532. 2016
  • Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials.  114:546-557. 2015
  • External validation of the hit expert probability (HEP) score.  113:633-640. 2015
  • The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism: From the women’s health initiative randomized controlled trial.  113:988-998. 2015
  • Compromised shear-dependent cleavage of type 2N von willebrand factor variants by ADAMTS13 in the presence of factor VIII.  110:202-204. 2013
  • Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.  107:232-240. 2012
  • Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.  106:947-958. 2011
  • The effect of plasminogen activator inhibitor type 1 on apoptosis.  100:1037-1040. 2008
  • Stem cells for clinical use in cardiovascular medicine: Current limitations and future perspectives.  94:697-701. 2005
  • Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The women's health initiative observational study.  93:1108-1116. 2005
  • Moderate wine and alcohol consumption: Beneficial effects on cardiovascular disease.  86:517-528. 2001
  • Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency.  81:189-192. 1999
  • Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets.  77:163-167. 1997
  • International Standard Serial Number (issn)

  • 0340-6245